The Use of Double Test Biomarkers to Predict Fetal Nuchal Translucency Thickness in the Diagnosis of Trisomy 21: A Compromise between Sensitivity and Specificity. (2018). Central Asian Journal of Medical Sciences, 4(3), 230-237. https://doi.org/10.24079/cajms.2018.09.009